NCT02060552View on ClinicalTrials.gov

Immune Molecular and Inflammatory Cytokines Dysfunction Analysis in Gout Patients With Different Urate Levels

PHASE4CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

April 30, 2014

Conditions
Primary Gout
Interventions
DRUG

Diacerein

oral administration of IL-1βinhibitory

DRUG

Colchicine

"Colchicine is a toxic natural product and secondary metabolite, originally extracted from plants of the genus Colchicum (autumn crocus, Colchicum autumnale, also known as meadow saffron). It was used originally to treat rheumatic complaints, especially gout as the positive control"

DRUG

Febuxostat

A urate lowering drug, an inhibitor of xanthine oxidase that is indicated for use in the treatment of hyperuricemia and gout

Trial Locations (1)

430030

Yikai YU, Wuhan

All Listed Sponsors
lead

Tongji Hospital

OTHER

NCT02060552 - Immune Molecular and Inflammatory Cytokines Dysfunction Analysis in Gout Patients With Different Urate Levels | Biotech Hunter | Biotech Hunter